Increased mortality associated with treated active tuberculosis in HIV-infected adults in Tanzania

Tuberculosis

Volumn 93, Issue 4, 2013, Pages 461-466

  Kabali, Conrad ^a   Mtei, Lillian ^b   Brooks, Daniel R ^c   Waddell, Richard ^d   Bakari, Muhammad ^b   Matee, Mecky ^b   Arbeit, Robert D ^e   Pallangyo, Kisali ^b   Von Reyn, C Fordham ^d   Horsburgh, C Robert ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^c BOSTON UNIVERSITY   (United States)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CD4 counts; Survival; TB prevention

Indexed keywords

BCG VACCINE; ISONIAZID;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TANZANIA; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TANZANIA; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS VACCINES; YOUNG ADULT;

EID: 84878916583     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2013.01.001     Document Type: Article

References (21)

1. E.L. Corbett, B. Marston, G.J. Churchyard, and K.M. De Cock Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment Lancet 367 2006 926 937
2. WHO. Global tuberculosis control - epidemiology, strategy, financing. WHO Report 2009. WHO/HTM/TB/2009.411.
3. S.M. Hammer, K.E. Squires, M.D. Hughes, J.M. Grimes, L.M. Demeter, J.S. Currier, J.J. Eron Jr., J.E. Feinberg, H.H. Balfour Jr., L.R. Deyton, J.A. Chodakewitz, M.A. Fischl, J.P. Phair, L. Pedneault, B. Nguyen, and J.C. Cook A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less New Engl J Med 337 1997 725 733
4. UNAIDS. 2008 Report on the Global AIDS epidemic. UNAIDS/08.27E/JC1511E.
5. M.A.B. van der Sande, M.F. Schim van der Loeffa, R.C. Bennett, M. Dowling, A.A. Aveika, T.O. Togun, S. Sabally, D. Jeffries, R.A. Adegbola, R. Sarge-Njie, A. Jaye, T. Corrah, S. McConkey, and H.C. Whittle Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2 AIDS 18 2004 1933 1941
6. M. Badri, R. Ehrlich, R. Wood, T. Pulerwitz, and G. Maartens Association between tuberculosis and HIV disease progression in a high tuberculosis prevalence area Int J Tuberc Lung Dis 5 3 2001 225 232
7. C. Whalen, C.R. Horsburgh, D. Hom, C. Lahart, M. Simberkoff, and J. Ellner Accelerated course of human immunodeficiency virus infection after tuberculosis Am J Respir Crit Care Med 151 1 1995 129 135
8. C.C. Whalen, P. Nsubuga, A. Okwera, J.L. Johnson, D.L. Hom, N.L. Michael, R.D. Mugerwa, and J.J. Ellnerb Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda AIDS 14 2000 1219 1228
9. S.S. Munsiff, P.L. Alpert, M.N. Gourevitch, C.J. Chang, and R.S. Klein A prospective study of tuberculosis and HIV disease progression J Acquir Immune Defic Syndr Hum Retrovirol 19 1998 361 366
10. V. Leroy, L.R. Salmi, M. Dupon, A. Sentilhes, J. Texier-Maugein, L. Dequae, F. Dabis, and R. Salamon Progression of human immunodeficiency virus infection in patients with tuberculosis disease. A cohort study in Bordeaux, France, 1988-1994 The Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA) Am J Epidemiol 145 1997 293 300
11. S.S. Abdool Karim, K. Naidoo, A. Grobler, N. Padayatchi, C. Baxter, A. Gray, T. Gengiah, G. Nair, S. Bamber, A. Singh, M. Khan, J. Pienaar, W. El-Sadr, G. Friedland, and Q. Abdool Karim Timing of initiation of antiretroviral drugs during tuberculosis therapy N Engl J Med 362 2010 697 706
12. F. Blanc, T. Sok, D. Laureillard, L. Borand, C. Rekacewicz, E. Nerrienet, Y. Madec, O. Marcy, S. Chan, N. Prak, C. Kim, K.K. Lak, C. Hak, B. Dim, C.I. Sin, S. Sun, B. Guillard, B. Sar, S. Vong, M. Fernandez, L. Fox, J. Delfraissy, and A.E. Goldfeld Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis N Engl J Med 365 2011 1471 1481
13. D.V. Havlir, M.A. Kendall, P. Ive, J. Kumwenda, S. Swindells, S.S. Qasba, A.F. Luetkemeyer, E. Hogg, J.F. Rooney, X. Wu, M.C. Hosseinipour, U. Lalloo, V.G. Veloso, F.F. Some, N. Kumarasamy, N. Padayatchi, B.R. Santos, S. Reid, J. Hakim, L. Mohapi, P. Mugyenyi, J. Sanchez, J.R. Lama, J.W. Pape, A. Sanchez, A. Asmelash, E. Moko, F. Sawe, J. Andersen, and I. Sanne Timing of antiretroviral therapy for HIV-1 infection and tuberculosis N Engl J Med 365 2011 1482 1491
14. C.F. von Reyn, L. Mtei, R.D. Arbeit, R. Waddell, B. Cole, T. Mackenzie, M. Matee, M. Bakari, S. Tvaroha, L.V. Adams, C.R. Horsburgh, and K. Pallangyo Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine AIDS 24 2010 675 685
15. National AIDS Control Programme National guidelines for the management of HIV and AIDS 3rd ed. 2008 NACP
16. L.V. Adams, B.N. Kreiswirth, R.D. Arbeit, H. Soini, L. Mtei, M. Matee, M. Bakari, T. Lahey, W. Wieland-Alter, E. Shashkina, N. Kurepina, J.R. Driscoll, K. Pallangyo, C.R. Horsburgh, and C.F. von Reyn Molecular epidemiology of HIV-associated Tuberculosis in Dar es Salaam, Tanzania: strain predominance, clustering, and polyclonal disease J Clin Microbiol 50 8 2012 2645
17. J.G. Pasipanodya, T.L. Miller, M. Vecino, G. Munguia, R. Garmon, S. Bae, G. Drewyer, and S.E. Weis Pulmonary impairment after tuberculosis Chest 131 2007 1817 1824
18. 3 reduces immune activation with no effect on HIV load or CD4 count PLoS One 5 2010 e9138
19. D.J. Martin, J.G. Sim, G.J. Sole, L. Rymer, S. Shalekoff, A.B. van Niekerk, P. Becker, C.N. Weilbach, J. Iwanik, and K. Keddy CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis J Acquir Immune Defic Syndr 8 1995 386 391
20. P. Glaziou, K. Floyd, E.L. Korenromp, C. Sismanidis, A.L. Bierrenbach, B.G. Williams, R. Atun, and M. Raviglione Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality Bull World Health Organ 89 2011 573 582
21. World Health Organization. WHO Three I's Meeting: intensified case finding (ICF), isoniazid preventive therapy, (IPT) and TB infection control (IC) for people living with HIV. In Report of a joint World Health Organization HIV/AIDS and TB department meeting; 2008.